Annual report pursuant to Section 13 and 15(d)

12. Share-Based Compensation (Tables)

v3.8.0.1
12. Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of Share-Based Compensation Expense
    Year Ended December 31,  
    2017     2016  
Research and development expenses   $ 101,401     $ 1,425,995  
General and administrative expenses     1,691,692       1,798,657  
    $ 1,793,093     $ 3,224,652  
Non-Vested Non-Employee Stock Options [Member]  
Option activity
    Number of
shares
    Weighted-
average
exercise
price
    Weighted-
average
remaining
life
(years)
    Aggregate
intrinsic
value
 
Outstanding as of January 1, 2016     57,442     $ 13.39       8.23     $ 220,764  
Granted                              
Outstanding as of December 31, 2016     57,442       7.57       7.23     $  
Granted                              
Expired     (723 )     10.34             $    
Outstanding as of December 31, 2017     56,719       7.53       6.31     $  
Vested or expected to vest as of December 31, 2017     56,719       7.53       6.31     $  
Exercisable as of December 31, 2016     47,341     $ 8.21       6.92     $  
Exercisable as of December 31, 2017     56,719     $ 7.53       6.31     $  
Common Stock Awards [Member]  
Common stock awards
    Number of shares  
Balance as of January 1, 2016     22,887  
Granted     26,760  
Issued     (19,857 )
Balance as of December 31, 2016     29,790  
Granted     41,800  
Settled in cash     (8,773 )
Balance as of December 31, 2017     62,817  
Employee Stock Options [Member]  
Assumptions used
    Year Ended December 31,  
    2017     2016  
Weighted-average expected dividend yield (%)            
Weighted-average expected volatility (%)     111.37       110.11  
Weighted-average risk-free interest rate (%)     1.79       1.63  
Weighted-average expected life of option (years)     5.36       5.92  
Weighted-average exercise price ($)     3.34       3.49  
Option activity
    Number of
shares
    Weighted-
average
exercise
price
    Weighted-
average
remaining
life
(years)
    Aggregate
intrinsic
value
 
Outstanding as of January 1, 2016     619,259       15.22       8.92     $ 1,915,942  
Granted     603,622       3.49                  
Expired     (29,169 )     12.38                  
Outstanding as of December 31, 2016     1,193,712       4.43       8.94     $ 526,073  
Granted     700,000       3.34                  
Expired     (113,343 )     4.61                  
Outstanding as of December 31, 2017     1,780,369       3.99       8.53     $ 5,273  
                                 
Vested or expected to vest as of December 31, 2017     1,755,369       4.02       8.51     $ 5,273  
                                 
Exercisable as of December 31, 2016     440,092     $ 5.60       8.94     $ 55,109  
Exercisable as of December 31, 2017     731,895     $ 4.84       7.44     $ 5,273  
Employee Stock Options [Member] | Non-Vested [Member]  
Option activity
    Number of
shares
    Weighted-
average
grant date
fair value
 
Balance as of January 1, 2017     753,620     $ 4.49  
Granted     700,000     $ 2.70  
Forfeited     (64,218 )   $ 6.15  
Vested     (340,928 )   $ 5.87  
Balance as of December 31, 2017     1,048,474     $ 2.86  
Non Employee Stock Options [Member] | Non-Vested [Member]  
Option activity
    Number of
shares
    Weighted-
average
grant date
fair value
 
Balance as of January 1, 2017     10,101     $ 13.13  
Vested     (10,101 )   $ 13.13  
Balance as of December 31, 2017         $